Nephromics & Abbott in pre-eclampsia pact
This article was originally published in Clinica
Executive Summary
Abbott Laboratories has joined the race to develop the first specific laboratory test for pre-eclampsia - a leading cause of maternal death - following a licensing agreement with Nephromics. Rival company Beckman Coulter signed a semi-exclusive licensing deal with Nephromics for the same intellectual property in July.